PAVmed to Host Business Update Call and Webcast
PAVmed Inc. (NASDAQ: PAVM, PAVMZ), a prominent player in the medical technology field, has announced plans to host a crucial business update conference call and webcast. This event is set to take place on March 25, 2025, starting at 8:30 AM ET. During this session, Lishan Aklog, M.D., the Company's Chairman and CEO, will present an overview of the operations and future growth strategies. It’s an exciting opportunity for those interested in medical tech advancements.
Conference Call Details
For those wishing to participate, the conference call can be accessed via telephone. U.S. participants should dial 1-800-836-8184, while international callers can reach the session by calling 1-646-357-8785. When connecting, listeners must mention the conference call title 'PAVmed Business Update' to ensure they are placed into the correct call.
Webcast Availability
The webcast of this significant update will be available in the investor relations section of PAVmed’s website. This accessibility allows attendees to tune in from anywhere and not miss any important discussion points regarding the Company's strategic direction.
Replay of Conference Call
Those unable to attend the live call can still access the replay, which will be available for 30 days following the event. Interested individuals are encouraged to visit the investor relations website for more information and updates.
Overview of PAVmed's Scope of Work
PAVmed Inc. stands out as a diversified commercial-stage medical technology company. Its focus spans various sectors, including medical devices, diagnostics, and digital health. A key part of its operation is its subsidiary, Lucid Diagnostics (NASDAQ: LUCD), which specializes in cancer prevention diagnostic solutions. Their flagship products include the EsoGuard Esophageal DNA Test and the EsoCheck Esophageal Cell Collection Device, which play a critical role in the early detection of esophageal cancer.
Innovations in Personal Health Monitoring
Moreover, PAVmed’s subsidiary, Veris Health Inc., is making remarkable strides in digital health. This branch is dedicated to advancing personalized cancer care using remote patient monitoring technologies, aiming to enhance patient quality of life. Veris is also working on an implantable physiological monitor set to revolutionize how cancer patients receive ongoing monitoring and support.
A Bright Future Ahead for PAVmed
As PAVmed continues to innovate within the healthcare industry, it is well-positioned for future growth. The upcoming conference call is expected to shed light on their strategic plans and operational updates, keeping investors and the public informed. The management's transparency during this call demonstrates the company's commitment to stakeholder communication and responsible governance.
Invitation to Follow PAVmed
For more information on PAVmed and to stay up-to-date with all latest developments, it’s recommended to visit their official website. This resource provides comprehensive details on their current endeavors and future projects within the dynamic medical technology landscape.
Frequently Asked Questions
What is the purpose of the upcoming conference call?
The conference call will provide essential updates about PAVmed's operations and financial performance, directly from top executives.
How can I access the conference call?
You can participate by calling 1-800-836-8184 in the U.S. or 1-646-357-8785 internationally, using the call name 'PAVmed Business Update'.
Is there a way to listen to the conference later?
Yes, a replay will be accessible for 30 days on the investor relations section of PAVmed’s website.
What key updates will be shared during the call?
The call will feature insights on the Company’s growth strategy and operations, along with financial results from the previous quarter.
What are PAVmed’s key subsidiaries?
PAVmed’s key subsidiaries include Lucid Diagnostics and Veris Health Inc., both of which focus on significant advancements in medical diagnostics and digital health solutions.
